United States 111th Congress Status: Died

HRES 1309 — Expressing the sense of the House of Representatives that there is need for further study of the Functional Gastrointestinal Disorder (FGID) Irritable Bowel Syndrome (IBS).

Last action — Referred to the Subcommittee on Military Personnel.

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. Died in session

This bill died with 111th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Calls for the Director of the National Institutes of Health (NIH) to take a leadership role in the search for new treatment options and a cure for Irritable Bowel Syndrome (IBS) by: (1) encouraging the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to implement the research recommendations of the National Commission on Digestive Diseases; (2) exploring collaborative research opportunities between the NIDDK, the Office of Research on Women's Health, and other NIH Institutes and Centers; and (3) encouraging NIDDK to provide the necessary funding for continued expansion and advancement of the IBS research portfolio and for education with respect to IBS and Functional Gastrointestinal Disorders (FGIDs) through the cosponsorship of workshops and seminars with patient organizations. Expresses the sense of the House of Representatives that: (1) funding should be increased for basic and clinical biomedical research into IBS and other FGIDs through NIH; (2) the Director of the Food and Drug Administration (FDA) should take a leadership role in ensuring that new IBS treatments are developed and appropriately monitored; and (3) the Department of Defense (DOD) and the Department of Veterans Affairs (VA) should bolster their efforts to study IBS and FGIDs and their association with war trauma.

Bill Text

We don't have the full text on file for this bill yet.

Read HRES 1309 on the official United States source →

Action History

  1. Referred to the Subcommittee on Military Personnel.

  2. Referred to House Veterans' Affairs

  3. Referred to House Armed Services

  4. Referred to House Energy and Commerce

  5. Referred to the Committee on Energy and Commerce, and in addition to the Committees on Armed Services, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Sponsorship breakdown

Export CSV (upgrade) →

0 sponsors · 0 co-sponsors · 547 not signed on

Sponsors (0)

None.

Co-sponsors (0)

None.

Not signed on (547)

547 members have not signed on to this bill.

Show all 547 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

veterans healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HRES 1309 do?
Calls for the Director of the National Institutes of Health (NIH) to take a leadership role in the search for new treatment options and a cure for Irritable Bowel Syndrome (IBS) by: (1) encouraging the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to implement the research recommendations of the National Commission on Digestive Diseases; (2) exploring collaborative research opportunities between the NIDDK, the Office of Research on Women's Health, and other NIH Institutes and Centers; and (3) encouraging NIDDK to provide the necessary funding for continued expansion and advancement of the IBS research portfolio and for education with respect to IBS and Functional Gastrointestinal Disorders (FGIDs) through the cosponsorship of workshops and seminars with patient organizations. Expresses the sense of the House of Representatives that: (1) funding should be increased for basic and clinical biomedical research into IBS and other FGIDs through NIH; (2) the Director of the Food and Drug Administration (FDA) should take a leadership role in ensuring that new IBS treatments are developed and appropriately monitored; and (3) the Department of Defense (DOD) and the Department of Veterans Affairs (VA) should bolster their efforts to study IBS and FGIDs and their association with war trauma.
What is the current status of HRES 1309?
This bill died with 111th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HRES 1309?
Track HRES 1309 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HRES 1309

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HRES 1309

Last checked for changes about 14 hours ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →